Brown & Brown prices $4 billion common stock offering for acquisition

Brown & Brown (BRO) has priced a public offering of 39.2 million shares at $102.00 per share, aiming to raise $4 billion to partially fund its $9.83 billion acquisition of Accession Risk Management Group. The offering, expected to close June 12, 2025, includes an underwriter option for an additional $400 million in shares; net proceeds are estimated at $3.9 billion if the option is not exercised. This follows a recent Goldman Sachs downgrade of BRO from Buy to Neutral with a price target of $119, citing expected organic growth aligning with peers.

Analysis

Brown & Brown, Inc. is undertaking a significant capital raise via a public offering of 39.2 million common shares at $102.00 per share, aiming for $4 billion in gross proceeds, with underwriters holding an option for an additional $400 million. The estimated net proceeds of approximately $3.9 billion are primarily designated to fund a portion of the substantial $9.83 billion acquisition of Accession Risk Management Group, the parent company of Risk Strategies, which is slated to close in the third quarter of 2025. This major strategic move occurs alongside recent Q1 2025 financial results where Brown & Brown met earnings per share expectations at $1.29 but slightly missed revenue forecasts, reporting $1.4 billion against an expected $1.41 billion, though still achieving a strong 11.6% year-over-year revenue increase and completing 13 acquisitions. Concurrently, Goldman Sachs has revised its stance on Brown & Brown, downgrading the stock from Buy to Neutral with a price target of $119, citing an anticipation that the company's organic growth will normalize to be more in line with its peers. The company also continues its smaller-scale M&A strategy, exemplified by its subsidiary Bridge Specialty Group's acquisition of Tim Parkman, Inc., underscoring its ongoing efforts to expand market presence.

Key Decisions for Investors

• Investors should carefully weigh the potential earnings per share dilution resulting from the $4 billion equity offering against the strategic rationale and anticipated long-term growth contributions from the large-scale Accession Risk Management acquisition.
• The recent Goldman Sachs downgrade to Neutral, accompanied by a $119 price target and expectations of organic growth aligning with peers, suggests a need to temper near-term return expectations and re-evaluate the stock's valuation multiple.
• Monitor the successful integration of Accession Risk Management following its expected Q3 2025 closing and the company's subsequent capital structure management, as these will be critical determinants of future performance and shareholder value.